Sinovac's COVID Vaccine Over 50% Effective in Brazil Tests: Report

Sinovac Biotech’s vaccine against COVID-19 is over 50% effective in late-stage trials, newspaper Folha de S. Paulo reported.
Reuters Health Information

Source link